Mastering Pathology for NEET-PG and INI-CET in Just 6 Days

Pathology — 6‑Day High-Yield Study Plan (NEET‑PG & INI‑CET)

Strategy:

  • Time: 7.5–8.5 hours/day in 60–75 min blocks.
  • Practice: 150–180 MCQs/day (Focus: Image‑based + Clinical vignettes).
  • Daily Task: Build 6–8 mini‑cards for "Volatile" data (IHC, Translocations, CD markers).

Day 1 — General Pathology I

Focus: Mechanisms of Disease, Mediators, and Immunity

1. Cellular Injury & Adaptations

  • Reversible Injury: Cellular swelling (hydropic), fatty change (liver/heart), blebs, ribosome detachment.
  • Reperfusion Injury: Mechanism involving ROS and Ca²⁺ influx.
  • Irreversible Injury (Necrosis):
    • Coagulative: Ischemia (except brain), preserved architecture.
    • Liquefactive: Brain, Abscess (neutrophils).
    • Caseous: TB, Fungal.
    • Fat: Pancreatitis (saponification), Trauma.
    • Fibrinoid: Malignant HTN, Vasculitis (Type III reaction).
    • Gangrene: Dry vs Wet.
  • Apoptosis:

    • Intrinsic: BAX/BAK (pro-apoptotic), BCL-2 (anti-apoptotic), Cyt-c leaks, Caspase 9.
    • Extrinsic: Fas/FasL, TNF, Caspase 8.
    • Morphology: Cell shrinkage, Pyknosis, Councilman bodies (Viral hepatitis).
  • Newer Cell Death Types (INI-CET High Yield):

    • Necroptosis: Programmed necrosis, Caspase-independent (RIPK1/RIPK3).
    • Pyroptosis: Inflammasome-mediated, IL-1 release (Fever), infectious.
  • Pigments & Calcification:
    • Lipofuscin: Wear-and-tear, perinuclear.
    • Dystrophic Calcification: Normal Ca²⁺, Damaged tissue (TB, Atheroma, Psammoma bodies).
    • Metastatic Calcification: High Ca²⁺, Normal tissue (HyperPTH, Vit D toxicity).

2. Acute Inflammation

  • Vascular: Lewis triple response, increased permeability (endothelial contraction).
  • Cellular Events (Must Know):
    • Rolling: Selectins (P-selectin, E-selectin).
    • Adhesion: Integrins (LFA-1, Mac-1) + ICAM/VCAM. Defect = LAD Type 1 (Delayed umbilical cord separation).
    • Diapedesis: PECAM-1 (CD31).
    • Chemotaxis: IL-8 (Major neutrophil chemotaxin), C5a, LTB4.
    • Phagocytosis: Opsonins (IgG, C3b); MPO/HOCl burst (killing).
  • Defects:
    • Chediak–Higashi: Giant lysosomal granules, albinism, neuropathy.
    • CGD: NADPH oxidase defect, NBT test negative (colorless).
  • Mediators:
    • Histamine/Serotonin: Vasodilation.
    • Arachidonic Acid: Prostaglandins (Pain/Fever), Leukotrienes (Bronchospasm/Chemotaxis).
    • Cytokines: IL-1 & TNF (Fever, Shock, Acute phase).

3. Chronic Inflammation & Healing

  • Granulomas:

    • Caseating: TB (Langhans giant cells, horseshoe nuclei).
    • Non-caseating: Sarcoidosis (Asteroid/Schaumann bodies), Crohn’s, Berylliosis.
  • Wound Healing:

    • Collagen Types: Type III (Granulation tissue) → Type I (Scar/Bone).
    • Vitamin C: Hydroxylation of Proline/Lysine.
    • Zinc: Matrix metalloproteinases (remodeling).
    • Primary vs Secondary Intention: Contraction by Myofibroblasts.

Day 1 MCQ Focus: Apoptosis pathways (Caspases), LAD vs CGD scenarios, Granuloma histology, Necrosis types.

Day 2 — General Pathology II

Focus: Neoplasia (Highest Weightage), Genetics, Hemodynamics

1. Hemodynamics

  • Thrombosis: Virchow triad (Endothelial injury, Stasis, Hypercoagulability). Lines of Zahn (Arterial/Pre-mortem).
  • Embolism:
    • Fat Embolism: Fracture + Petechial rash + Hypoxemia.
    • Amniotic Fluid: Fetal squames in lung + DIC.
    • Air Embolism: Decompression sickness (Caisson disease).
  • Infarction: Red (dual supply - lung/liver) vs White (end artery - heart/kidney/spleen).
  • Shock:

    • Septic: LPS → TLR4 → Cytokine Storm (TNF/IL-1).
    • Stages: Non-progressive → Progressive (Anaerobic glycolysis) → Irreversible.

2. Neoplasia (Crucial)

  • Carcinogenesis:

    • Oncogenes: RAS (Pancreas/Colon), MYC (Burkitt), HER2 (Breast), RET (MEN2).
    • Tumor Suppressors: Rb (Retinoblastoma/Osteosarcoma), p53 (Li-Fraumeni - "Guardian"), APC (Colon).
    • Apoptosis Evasion: BCL-2 (Follicular lymphoma).
  • Invasion: Loss of E-cadherin, MMPs degrade basement membrane.

  • Tumor Markers: AFP (HCC/Yolk sac), CEA (Colon), CA-125 (Ovary), CA 19-9 (Pancreas), β-hCG (Choriocarcinoma).

  • The IHC Cheat Sheet (Memorize):

    • CD45 (LCA): Lymphoma
    • Cytokeratin (CK): Carcinoma (Epithelial)
    • Vimentin: Sarcoma (Mesenchymal)
    • Desmin: Muscle (Rhabdo/Leiomyoma)
    • S-100 / HMB-45: Melanoma
    • Chromogranin / Synaptophysin: Neuroendocrine

3. Genetics & Amyloidosis

  • Chromosomal: Down (Tri 21), Turner (45XO), Klinefelter (47XXY).
  • Lysosomal Storage:
    • Gaucher: Crumpled tissue paper cells (Glucocerebrosidase).
    • Niemann-Pick: Cherry red spot + Hepatosplenomegaly.
    • Tay-Sachs: Cherry red spot + CNS only (No hepatosplenomegaly).
  • Amyloidosis: Congo Red Stain → Apple-Green Birefringence under polarized light.

    • AL (Light chain - Myeloma), AA (Chronic inflammation), Aβ (Alzheimer).

Day 2 MCQ Focus: Virchow triad, Tumor markers, Oncogene associations, IHC markers, Storage disease enzymes.

Day 3 — Hematopathology

Focus: Leukemias, Translocations, Anemia Labs

1. Red Cell Disorders

  • Microcytic Anemia:
    • IDA: Low Ferritin, High TIBC, High RDW.
    • Thalassemia: Normal/High Ferritin, Target Cells, Mentzer Index < 13.
  • Hemolytic Anemia:

    • Hereditary Spherocytosis: Osmotic fragility increased, MCHC increased.
    • G6PD: Oxidative stress, Heinz bodies, Bite cells.
    • Sickle Cell: HbS, Autosplenectomy (Howell-Jolly bodies), Vaso-occlusion.
    • PNH: Acquired defect (PIGA gene), CD55/CD59 deficiency, Thrombosis risk.

2. Bleeding & Coagulation

  • Platelet vs Coag: Mucosal bleed/Petechiae (Platelet) vs Hemarthrosis/Deep bleed (Coag factors).

  • Disorders:

    • Hemophilia A: Factor VIII, High APTT.
    • vWD: High Bleeding Time + High APTT.
    • Bernard-Soulier: GpIb defect (Giant platelets).
    • Glanzmann: GpIIb/IIIa defect.
  • Transfusion Reactions (High Yield):
    • TRALI: Antibody against recipient WBC → Lung damage/Hypoxia.
    • TACO: Fluid overload → responds to diuretics.

3. Leukemias & Lymphomas (The Translocation Grid)

  • Acute:

    • AML: Auer Rods, MPO+, t(15;17) APML (Treat with ATRA).
    • ALL: TdT+, PAS+, Children.
  • Chronic:

    • CML: t(9;22) Philadelphia Ch., BCR-ABL, Low LAP score.
    • CLL: Smudge cells, CD5+/CD23+.
    • Hairy Cell Leukemia: TRAP+, Dry tap, Massive splenomegaly.
  • Lymphomas:

    • Hodgkin: Reed-Sternberg cells (Owl eye), CD15+, CD30+.
    • Burkitt: t(8;14) c-MYC, Starry Sky appearance.
    • Follicular: t(14;18) BCL-2.
    • Mantle Cell: t(11;14) Cyclin D1.

Day 3 MCQ Focus: Anemia lab profiles, Translocation matching, Smear identification (Auer rods, Target cells), TRALI vs TACO.

Day 4 — Systemic Pathology I

Focus: CVS, Respiratory, GI

1. Cardiovascular

  • MI Pathology:
    • 4–12 hrs: Contraction bands.
    • 1–3 days: Neutrophils (Yellow center).
    • 3–7 days: Macrophages (Risk of rupture highest).
  • Vasculitis:
    • Kawasaki: Coronary aneurysms (CRASH & Burn).
    • Wegener (GPA): c-ANCA, Sinus/Lung/Kidney.
    • Churg-Strauss: p-ANCA, Asthma, Eosinophilia.
  • RHD: Aschoff bodies, Anitschkow cells (Caterpillar nucleus).

2. Respiratory

  • Obstructive:
    • Emphysema: Centriacinar (Smoking) vs Panacinar (A1AT deficiency).
    • Asthma: Curschmann spirals, Charcot–Leyden crystals.
  • Restrictive (Pneumoconiosis):
    • Silicosis: Eggshell calcification, TB risk increased.
    • Asbestosis: Ferruginous bodies, Lower lobes, Mesothelioma.
  • Lung Tumors:
    • Squamous: Central, Cavitation, Keratin Pearls, PTHrP (Hypercalcemia).
    • Adenocarcinoma: Peripheral, TTF-1, Non-smokers.
    • Small Cell: Central, Neuroendocrine, ACTH/ADH (Paraneoplastic).

3. GI Pathology

  • Stomach:
    • MALToma: H. pylori associated.
    • Adenocarcinoma: Intestinal vs Diffuse (Signet Ring cells / Linitis Plastica / Virchow Node).
  • IBD Comparison:
    • Crohn: Skip lesions, Transmural, Non-caseating granulomas, String sign.
    • UC: Continuous, Mucosal only, Crypt abscesses, Lead pipe colon, PSC link.

Day 4 MCQ Focus: MI timeline complications, Vasculitis ANCA types, Lung tumor paraneoplastic syndromes, Crohn vs UC features.

Day 5 — Systemic Pathology II

Focus: Renal, Hepatobiliary, Endocrine

1. Renal (Nephritic vs Nephrotic)

Feature

Nephritic (Inflammation)

Nephrotic (Proteinuria >3.5g)

Presentation

Hematuria, RBC Casts, HTN

Edema, Lipiduria, Frothy urine

PSGN

Subepithelial "Humps"

 

RPGN

Crescents (Fibrin/Macrophages)

 

Minimal Change

 

Foot process effacement (EM)

Membranous

 

Spike & Dome (Subepithelial)

FSGS

 

Focal sclerosis (HIV/Heroin)

Diabetic

 

Kimmelstiel–Wilson Nodules

MPGN

 

Tram-track appearance

2. Hepatobiliary & Pancreas

  • Hepatitis: Ballooning degeneration, Councilman bodies.
  • Alcoholic Liver: Mallory-Denk bodies (Cytokeratin).
  • Cirrhosis: Stellate cells (Ito cells) cause fibrosis.
  • Pancreas: Trousseau sign (migratory thrombophlebitis in Ca Pancreas), CA 19-9.

3. Endocrine & Reproductive

  • Thyroid:
    • Papillary Ca: Orphan Annie eyes, Psammoma bodies, BRAF mutation.
    • Medullary Ca: C-cells (Calcitonin), Amyloid stroma, RET mutation.
  • Ovary:
    • Yolk Sac Tumor: Schiller-Duval bodies (Glomeruloid), AFP high.
    • Granulosa Cell Tumor: Call-Exner bodies, Inhibin high.
  • Cervix: HPV 16/18 (E6 inhibits p53, E7 inhibits Rb).

Day 5 MCQ Focus: Glomerular deposits (Humps vs Spikes), Thyroid histology buzzwords, Ovarian tumor bodies.

Day 6 — Systemic Pathology III & Updates

Focus: Skin, Bone, CNS, Molecular

1. Skin (Dermpath Buzzwords)

  • Psoriasis: Parakeratosis, Munro microabscesses (Neutrophils in corneum).
  • Lichen Planus: Saw-tooth rete ridges, Civatte bodies, Wickham striae.
  • Bullous Lesions:
    • Pemphigus Vulgaris: Anti-desmoglein, Intraepidermal, Net-like IF.
    • Bullous Pemphigoid: Anti-Hemidesmosome, Subepidermal, Linear IF.

2. Bone & Soft Tissue

  • Osteosarcoma: Codman’s Triangle, Sunburst appearance, Rb mutation.
  • Ewing Sarcoma: Onion-skinning, t(11;22), CD99+.
  • Giant Cell Tumor: Soap Bubble appearance (Epiphysis).
  • Soft Tissue: Liposarcoma (Lipoblasts), Rhabdomyosarcoma (Strap cells, Desmin+).

3. CNS Tumors

  • Glioblastoma: Pseudopalisading necrosis, Butterfly lesion.
  • Meningioma: Whorled pattern, Psammoma bodies.
  • Schwannoma: Antoni A (Cellular) & Antoni B (Hypocellular), Verocay bodies.
  • Medulloblastoma: Homer-Wright Rosettes (Cerebellum in kids).

4. Recent Advances (INI-CET Must)

  • Techniques:
    • FISH: For Translocations/Gene amplification.
    • Flow Cytometry: Cell surface markers (Leukemia typing).
    • Liquid Biopsy: Detects ctDNA (circulating tumor DNA).
  • Targetable Mutations: EGFR (Lung), HER2 (Breast), BRAF (Melanoma/Thyroid), ALK (Lung).

Day 6 MCQ Focus: Bone X-ray signs, Pemphigus vs Pemphigoid IF, CNS tumor histology patterns.

Back to blog